Deaths due to suspected hypothermia in sheep and alpacas on a Manawatu farm in New Zealand in mid-summer.

CASE HISTORY: In mid-summer (February), 42 of a flock of 68 ram hoggets (approximately 5 months of age) and two of a group of 14 alpacas on a farm in the Manawatu region of New Zealand were found recumbent or dead following a period of persistent rain, strong winds and relatively low temperatures. The hoggets and alpacas had been shorn 4 and 53 days previously, respectively, and were in adequate to good body condition with access to ad libitum pasture. Post-mortem and histological examinations were undertaken on four hoggets and two alpacas. CLINICAL FINDINGS: Apart from hypothermic body temperatures from four recumbent hoggets, nothing of significance was identified on clinical or gross pathological examination. Histological changes of vacuolar hepatopathy, renal tubular degeneration and pulmonary congestion were present in all animals examined. DIAGNOSIS: Based on the history and clinical and pathological findings, hypothermia was highly probable to have been the cause of the deaths. CLINICAL RELEVANCE: These cases emphasise the importance of shelter for recently shorn sheep and alpacas regardless of the season.

Protothecosis in four dogs in New Zealand.

CASE HISTORIES: Medical records of four dogs diagnosed with protothecosis in New Zealand were reviewed. The dogs were aged between 4 and 9 years and three of the four dogs were female. Breeds were one Labrador, one Miniature Schnauzer and two crossbreeds. The reasons for initial veterinary evaluation were a cough and opaque appearance of the right eye (Case 1), diarrhoea (Cases 2 and 3), and cutaneous disease (Case 4). CLINICAL FINDINGS: The ocular signs were characterised by panuveitis, retinal detachment and secondary glaucoma. Gastrointestinal signs included chronic haemorrhagic diarrhoea due to colitis. Three cases had disseminated infection and developed both bilateral, blinding, ocular disease and chronic gastrointestinal disease. Cutaneous signs consisted of draining fistulae over the olecranon, multifocal cutaneous nodules, and ulceration and tracts of the foot pads. Disseminated protothecosis was confirmed by histopathology of biopsied ocular tissues in Cases 1 and 2 and by gastrointestinal biopsies in Case 3. Prototheca spp. were also identified in cytological specimens from Cases 1 and 4 and recovered by culture in Cases 2 and 4. Cutaneous protothecosis was diagnosed in Case 4 initially by cytology and histopathology of skin lesions, and Prototheca zopfii was confirmed by PCR of cultured organisms. TREATMENT AND OUTCOME: Prior to diagnosis of protothecosis, a variety of treatments were prescribed to treat the gastrointestinal and ocular signs. After diagnosis, only Cases 2 and 4 received medication aimed at treating the protothecal infection, which was itraconazole in both cases. Following the progression of clinical signs and concerns about quality of life, all four dogs were euthanised. DIAGNOSIS: Disseminated protothecosis in three dogs, cutaneous protothecosis in one dog. CLINICAL RELEVANCE: Canine protothecosis is rarely reported, despite the ubiquity of the causal algae, and the disease usually carries an extremely grave prognosis when infection is generalised. In New Zealand, protothecosis should be considered as a differential diagnosis in dogs with panuveitis, chorioretinitis or retinal detachment, colitis, or nodular, ulcerative or fistulating cutaneous lesions.

Causes of mortality of kiwi (Apteryx spp.) in New Zealand: a retrospective analysis of post-mortem records, 2010-2020.

AIMS: To examine and assess causes of mortality of kiwi (Apteryx spp.) submitted to Massey University between 2010 and 2020 across the five recognised species according to location, age group and captivity status in New Zealand. METHODS: Post-mortem reports were obtained from the Massey University/Te Kunenga ki Purehuroa School of Veterinary Science/Wildbase Pathology Register. Inclusion criteria were all species of kiwi with a date of post-mortem examination between August 2010 and August 2020. Data from each report was exported, categorised and compared using Microsoft Excel. RESULTS: Of a total of 1,005 post-mortem reports, there were 766 North Island brown kiwi (NIBK; A. mantelli), 83 tokoeka (A. australis), 73 rowi (A. rowi), 49 great spotted kiwi (A. haastii), and 34 little spotted kiwi (A. owenii). This comprised 19 eggs/embryos, 125 neonatal, 473 juvenile, 153 subadult, and 235 adult kiwi. There were 615 kiwi from wild populations, 148 from sanctuary populations, 238 from captivity, and four from unspecified locations. The leading cause of death was trauma, affecting 322 (32.0 (95% CI = 29.2-35.0)%) kiwi including 289 (37.3 (95% CI = 26.0-31.7)%) NIBK. Nearly half of these died from predation by mustelids, with losses recorded from neonates to adults and clustered in the central to southern North Island. Predation by dogs was the second most common cause of death, killing 84 (8.4 (95% CI = 6.7-10.2)%) kiwi, of which 65.5% came from the northern districts of the North Island. Non-infectious disease killed 214 (21 (95% CI = 18.8-24.0)%) kiwi, and included developmental deformities, gastrointestinal foreign bodies and predator trap injuries. Infectious disease killed 181 (18.0 (95% CI = 15.7-20.5)%) kiwi and the proportion decreased with age, with common diagnoses including coccidiosis, bacterial septicaemia, avian malaria, and fungal respiratory disease. Starvation affected 42 (4.2 (95% CI = 3.0-5.6)%) kiwi, comprised of mainly neonatal or juvenile individuals from wild or sanctuary populations, with a higher percentage seen in tokoeka (11/83; 13.3%) compared to other species (min 0%, max 5.9%). The cause of death was undetermined in 246 (24.5 (95% CI = 21.8-27.3)%) cases, which was most often due to poor preservation of remains. This included 33/73 (46%) rowi and 32/83 (39%) tokoeka, and affected mainly birds from sanctuary and wild populations. CONCLUSIONS: This study enhances our understanding of causes of mortality in captive, wild and sanctuary populations of all kiwi species and age groups within contemporary New Zealand.

Postural and gait abnormalities in a group of Romney lambs due to pain induced by severe chronic cutaneous dermatophilosis.

CASE HISTORY: Fifteen lambs from a flock of 1,000, 5-month-old Romney lambs in the Manawatu region of New Zealand, developed unusual postural and gait abnormalities during the summer of 2020. In mid-January, the lambs were grazing a raphanobrassica crop (xRaphanobrassica; Brassica oleracea x Raphanus sativus) but were removed from this crop soon after as they developed dermal lesions on the pinnae consistent with photosensitisation (colloquially known as "rape scald"). The lambs were placed onto a shaded paddock containing a pasture of predominantly perennial ryegrass (Lolium perenne) and white clover (Trifolium repens). One week following removal from the crop (late January), the 15 lambs developed abnormal postures and gaits that were described by farm staff as "neurological" and "swayback-like". CLINICAL FINDINGS: From a distance, all 15 lambs exhibited remarkably similar abnormal posture and gait whereby their weight was borne on their carpi, and they appeared to crawl while walking due to crouched hindquarters and prominent lordosis. Of the affected lambs, five were submitted for clinical examination. All five had normal vital signs. The results of neurological examinations were within normal limits. In response to palpation of the dorsum, the lambs performed an exaggerated and unusual dipping motion, particularly when pressure was applied over the lumbar spine. Parting of the fleece over the dorsum revealed thickened, indurated skin that cracked and tore easily. PATHOLOGICAL FINDINGS: The shorn pelt of a euthanised lamb revealed a large (100 cm × 40 cm), locally extensive, irregular ovoid region of the skin of the dorsum that was markedly thickened, indurated and crusted. Impression smears of the lesions revealed long filamentous chains of plump coccoid bacteria separated by transverse and longitudinal septa, consistent with Dermatophilus congolensis. Histopathology of the lesions revealed severe, chronic-active, locally extensive, necrosuppurative dermatitis with marked acanthosis, orthokeratotic and parakeratotic hyperkeratosis, ulceration, filamentous bacteria and coccoid zoospores. DIAGNOSIS: Cutaneous dermatophilosis due to Dermatophilus congolensis. CLINICAL RELEVANCE: Painful dermal lesions due to severe dermatophilosis of the dorsal skin of sheep are capable of causing postural and gait abnormalities that may be misinterpreted as signs of neurological abnormality. Such dermal lesions may be concealed by an apparently normal fleece.

First report of the use of mucosal swabs of the palatine tonsillar crypt for detection of Mycoplasma bovis in naturally infected calves.

Aims: To compare detection by real-time PCR of DNA from Mycoplasma bovis on mucosal swabs taken from the palatine tonsillar crypt and the mainstem bronchi of clinically asymptomatic calves after slaughter. Methods: We compared the sensitivity of mucosal swabs taken from two sites: the palatine tonsillar crypt and the mainstem bronchi. Paired samples were taken post-mortem at slaughter from 55 clinically well calves from an infected herd and were tested by real-time PCR for the presence of M. bovis-specific DNA. Results: Mycoplasma bovis DNA was detected in 51 palatine tonsillar crypt swabs (92.7 (95% CI = 82.4-98.0)%) and seven mainstem bronchial swabs (12.7 (95% CI = 5.3-24.5)%). All seven calves with positive mainstem bronchial swabs also had positive palatine tonsillar crypt swabs. Conclusions: When compared to mucosal swabs of the mainstem bronchi, mucosal swabs of the palatine tonsillar crypt were seven times more sensitive for the post-mortem detection of M. bovis DNA. The viability of detected M. bovis was not assessed, because any cattle carrying viable or non-viable M. bovis DNA were determined to be a potential risk to eradication. Palatine tonsillar crypt mucosa may be a useful anatomical site for real-time PCR detection of M. bovis DNA in naturally infected calves. More work is needed to define the persistence and viability of M. bovis at this anatomical site. Clinical relevance: The results of this study helped form the basis of surveillance tools used in M. bovis control and eradication efforts. Familiarity with these results may help veterinarians better communicate with their clients about the science behind the eradication efforts.

Urine retention in cattle putatively associated with injection of an ivermectin and closantel anthelmintic formulation into the ischiorectal fossa.

CASE HISTORY: A group of 39, 19-22-month-old Friesian bulls were administered an ivermectin/closantel anthelmintic via intended S/C injection in the ischiorectal fossa on 15 June 2017 (Day 0). Over the next 50 days, 22 affected bulls presented various degrees of anorexia, abdominal pain and urine dribbling. Seventeen bulls were examined by transrectal ultrasonography which revealed urinary bladder distension in all 17, and peritoneal fluid accumulation in some. Overall, eight bulls died or were subjected to euthanasia. On-farm postmortem examination of three bulls revealed urinary bladder rupture. CLINICAL FINDINGS: On Day 50 one affected live bull was admitted to Massey University for further investigation. This bull continuously dribbled urine and had an overtly distended urinary bladder as determined by rectal palpation and ultrasonography. PATHOLOGICAL FINDINGS: Postmortem examination of this bull revealed a markedly distended urinary bladder, massive subcapsular and pericapsular renal oedema with retroperitoneal fluid accumulation, minimal hydronephrosis and no evidence of mechanical urinary outflow obstruction. The right ischiorectal fossa contained multifocal areas of tissue fibrosis that extended into areas innervated by the distal cutaneous branch of the pudendal nerve and the pelvic nerve. Histopathological changes consisted of extensive fibrosis, myonecrosis and neurodegeneration, and evidence of granulation tissue and inflammation at the putative injection site and in surrounding tissues. DIAGNOSIS: A local inflammatory reaction at the presumed injection site together with localised peripheral neurodegeneration and myelopathy may have led to detrusor-sphincter dyssynergia causing urine retention. CLINICAL RELEVANCE: These cases of urine retention and bladder rupture in cattle were of putative iatrogenic origin. Veterinarians should be aware of this rare complication after S/C injections in the ischiorectal fossa.

Biological Variability in Serum Cortisol Concentration Post-adrenocorticotropic Hormone Stimulation in Healthy Dogs.

BACKGROUND: The ACTH stimulation has low sensitivity for the diagnosis of hypercortisolism possibly as a result of biological and analytical variability. HYPOTHESIS/OBJECTIVES: To report the components of biological and analytical variability in serum cortisol concentration post-ACTH stimulation ([cortisol]) in healthy dogs. ANIMALS: Fourteen healthy harrier hound dogs. METHODS: The data were extracted from a separate, prospective, randomized, double-blinded, controlled discovery study in which dogs treated with vehicle control and 4 different doses of cortisone acetate (CA) for 7 days had an ACTH stimulation test performed to confirm the dose-dependent effect of CA. The index of individuality (IoI), the critical difference between sequential measurements (CD ), and the number of measurements required to assess the homeostatic set point (HSP) of [cortisol] with confidence intervals (CI) of 90 and 95% were estimated. RESULTS: The IoI was equal to 1.1 and the CD was 3.3 µg/dL (92 nmol/L). The number of measurements required to assess the HSP of [cortisol] with CI of 90 and 95% were 3 and 15, respectively. Additionally, mean [cortisol] was higher in males than in females (13.3 ± 4 µg/dL [366 ± 114 nmol/L] vs. 11.5 ± 2.5 µg/dL [318 ± 65 nmol/L], respectively; P = .046). As expected, treatment with CA resulted in a dose-dependent suppression of [cortisol]. CONCLUSIONS AND CLINICAL IMPORTANCE: False-negative test results in hypercortisolism could occur when [cortisol] is outside of the individual's HSP and within the reference interval. The large CD emphasizes the importance of assessing clinically relevant parameters in the diagnosis and monitoring of HC.

Pheochromocytoma in Old World Primates (Macaca mulatta and Chlorocebus aethiops).

Pheochromocytoma, a rarely reported adrenal gland neoplasm in Old World primates, was diagnosed in 5 rhesus macaques (Macaca mulatta) and 2 African green monkeys (Chlorocebus aethiops) from 3 research institutions. Age and sex were available for 6 primates. Two males and 4 females were affected, ranging in age from 9 to 31 years. All neoplasms were unilateral and, in the cases reporting the affected gland, 4 involved the right adrenal gland and 2 involved the left. Diagnosis was established by characteristic histologic features. Immunohistochemically, neoplastic cells in all cases expressed chromogranin A and met-enkephalin and were negative for melan-A and inhibin. Six of 7 tumors were positive for ß-endorphin. Pulmonary metastases were present in 2 rhesus macaques and portal vein invasion in 1 African green monkey. To the authors' knowledge, this is the first report of malignant pheochromocytoma in Old World primates.

Sedative and mechanical hypoalgesic effects of butorphanol in xylazine-premedicated donkeys.

REASONS FOR PERFORMING STUDY: Combinations of α2 -adrenoceptor and opioid agonists are commonly used in equids, but little scientific information is available on donkeys. OBJECTIVES: To compare the sedative and hypoalgesic effects of xylazine alone or in combination with different dosages of butorphanol in donkeys. STUDY DESIGN: Placebo-controlled, operator-blinded, randomised, crossover, Latin square study. METHODS: Six donkeys received intravenous normal saline and normal saline (NS-NS); xylazine (0.5 mg/kg bwt) and normal saline (X-NS); xylazine and 10 µg/kg bwt butorphanol (X-B10); xylazine and 20 µg/kg bwt butorphanol (X-B20); xylazine and 30 µg/kg bwt butorphanol (X-B30); and xylazine and 40 µg/kg bwt butorphanol (X-B40). Sedation scores (SS), head height above ground (HHAG) and mechanical nociceptive thresholds (MNT) were assessed before and for 120 min after treatment. Areas under the curve (AUC) values for 0-30, 30-60 and 60-120 min were computed for SS, HHAG and MNT. As appropriate, differences between treatments were analysed using the Friedman test followed by Dunn's test and a repeated measures one-way analysis of variance followed by Tukey's test; significance was set at P<0.05. RESULTS: All treatments apart from NS-NS induced sedation. Butorphanol treatments induced significantly larger SS-AUC0 -30 values than those for NS-NS (P<0.05). Compared to corresponding NS-NS values, HHAG-AUC0 -30 values were significantly smaller for all other treatments (P<0.001) and HHAG-AUC30-60 values were significantly smaller for X-B40 (P<0.05). Compared to NS-NS, all treatments induced mechanical hypoalgesia and yielded significantly larger MNT-AUC0-30 values (P<0.001). Treatment X-NS yielded significantly smaller MNT-AUC0 -30 values than those for X-B30 and X-B40 (P<0.05). Only MNT-AUC30 -60 values for X-B30 and X-B40 were significantly larger than those for NS-NS and X-NS (P<0.05). CONCLUSIONS: Sedation and mechanical hypoalgesia induced by xylazine were enhanced by butorphanol at 40 µg/kg bwt. This drug combination may be suitable for chemical restraint of donkeys undergoing certain clinical procedures.

Alpha and gamma herpesvirus detection in two herds of farmed red deer (Cervus elaphus) in New Zealand.

CASE HISTORY: In September 2004 two hinds on Farm 1 were observed with epiphora and keratoconjunctivitis, and corneal scarring. A low pregnancy rate in some hinds had been recorded that year. In the same year six yearling deer were observed on Farm 2 with keratitis, uveitis and corneal scarring. CLINICAL AND PATHOLOGICAL FINDINGS: On Farm 1, conjunctival swabs and blood samples were collected from the hinds with ocular lesions, and from 24 other hinds. The two affected hinds were immunosuppressed with dexamethasone for 7 days. Conjunctival, nasal and vaginal swabs were collected daily before euthanasia and necropsy on the eighth day. Subsequently, another five non-pregnant hinds were similarly immunosuppressed and necropsied, and the reproductive tracts of 20 non-pregnant hinds were collected following slaughter. Semen samples were collected from four stags implicated with reproductive failure. On Farm 2, conjunctival swabs were collected from six hinds with ocular lesions and from 14 unaffected deer. Viral culture, consensus primer PCR and sequencing for specific herpesviruses was carried out on conjunctival swabs, buffy coat from blood samples, semen and reproductive tracts. Necropsy samples were also examined using gross pathology and histopathology. On Farm 1, a type 2 rhadinovirus (CvRhV) was detected in the conjunctiva of one hind with keratoconjunctivitis using PCR. Following immunosuppression, gross vesicular and histological vaginal lesions typical of infection with alphaherpesvirus were observed in samples of vaginal tissue from the same hind. Buffy coat, vaginal and lumbar spinal nervous tissues were also positive for cervid herpesvirus 1 (CvHV-1) using PCR. Herpesviruses were not detected in reproductive tracts, ocular or semen samples of the other deer. CvRhV was detected in buffy coats from four other hinds and in a conjunctival swab from one hind, all without ocular lesions, using PCR. On Farm 2, conjunctival swabs from two deer with keratitis were culture positive for CvHV-1. Two culture-negative conjunctival samples from deer without ocular lesions were positive for CvHV-1 by PCR. In two other affected animals, presence of CvRhV was confirmed by PCR and sequencing. DIAGNOSIS: Infection with CvHV-1 associated with keratitis and vulvovaginitis, and CvRhV infection in deer with and without ocular lesions. CLINICAL RELEVANCE: CvHV-1 is a likely cause of keratoconjunctivitis and possibly reproductive tract pathology in deer. Investigation of ocular lesions and reproductive failure in farmed deer should include CvRhV and CvHV-1.

Efficacy of tropicamide, homatropine, cyclopentolate, atropine and hyoscine as mydriatics in Angora goats.

AIM: To document the efficacy of five commercially available mydriatics for their potential for diagnostic and therapeutic use in Angora goats. METHODS: Over 8 weeks, the mydriatic effects of 1% tropicamide, 2% homatropine, 1% cyclopentolate, 1% atropine and 0.25% hyoscine were evaluated. Given as block treatments, drugs were applied randomly to one eye of 10 Angora goats, and the contralateral eye served as a control. Vertical and horizontal pupil diameters were measured to document onset of effect, time to reach a difference of 5 mm in the vertical/horizontal pupil diameter between eyes, time to maximum pupillary dilation, and duration of mydriatic action. RESULTS: Onset of mydriasis for all drugs occurred within 15 minutes. Time to reach a difference of 5 mm in the vertical pupil diameter between eyes was shortest for 1% tropicamide and 0.25% hyoscine (0.5 h), then 2% homatropine and 1% atropine (0.75 h), and longest for 1% cyclopentolate (1.5 h). The maximum vertical pupillary dilation occurred earliest with 1% tropicamide and 1% atropine (2 h), followed by 0.25% hyoscine (3 h), 2% homatropine (4 h), and latest with 1% cyclopentolate (8 h). The duration of vertical dilation of the pupil was shortest with 1% tropicamide (6 h), then 2% homatropine (12 h), 1% cyclopentolate (12 h), 1% atropine (24 h), and longest for 0.25% hyoscine (96 h). The time to reach maximum horizontal dilation of the pupil in treated eyes was shortest with 1% cyclopentolate (1 h), followed by 1% tropicamide (1.5 h), 0.25% hyoscine (3 h), 2% homatropine (3.5 h), and 1% atropine (4 h). The duration of horizontal pupil dilation was shortest with 1% tropicamide (4.5 h), and longest with 0.25% hyoscine (48 h). CONCLUSION: All five mydriatics induced clinical dilation. Tropicamide (1%) had the shortest duration of effect, but gave incomplete dilation. Good dilation was achieved with 1% cyclopentolate and 2% homatropine, but took too long to reach maximum dilation for routine mydriasis. The largest vertical dilation of the pupil was achieved with 1% atropine and 0.25% hyoscine, but pupils remained dilated for more than 24 h. CLINICAL RELEVANCE: For routine mydriasis in goats, it is recommended that 1% tropicamide be used, though there may be incomplete dilation. For a longer duration of mydriasis, such as in the treatment of anterior uveitis, 1% atropine or 0.25% hyoscine would be the drugs of choice.

Regional seroprevalence of leptospirosis on deer farms in New Zealand.

AIM: To undertake a seroprevalence survey to estimate the distribution of infection by Leptospira spp. serovars Hardjobovis, Pomona and Copenhageni in farmed deer herds regionally throughout New Zealand. METHODS: Between March 2003 and February 2005, 111 red and red x wapiti deer herds not using a leptospiral vaccine were selected from nine regions from Northland to Southland. Eighty-three herds were selected for on-farm collection of 12-20 blood samples from hinds predominantly 9-30 months of age, by jugular venepuncture, while similar numbers, predominantly males 9-30 months of age, per farm were collected from 28 herds at sticking at deer slaughter premises (DSP). Serum was stored frozen until analysed using the microscopic agglutination test (MAT). Titre cut-points of 1:24 for serovar Hardjobovis and 1:48 for serovars Pomona and Copenhageni were considered positive at the individual animal level. Herds were considered seropositive if there were at least three animals per herd seropositive to any serovar. RESULTS: Eighty-one percent of herds were seropositive for Leptospira spp. Hardjobovis was the predominant serovar at the herd (78%) and individual animal (60.8%) levels. The seroprevalence of Pomona was 20% and 8.4% at the herd and animal levels, respectively. Dual seroreactivity to both Hardjobovis and Pomona was observed in 16% of herds and 6.6% of individuals; within-herd seroprevalence for both serovars ranged from 0 to 100%. No herds and 1.2% of animals were seropositive for serovar Copenhageni. There was a regional difference in the prevalence of herds seropositive to both Hardjobovis and Pomona (p=0.02), but no difference between regions in the prevalence of herds seropositive to either Hardjobovis or Pomona alone. CONCLUSION: The seroprevalence of Leptospira spp. serovars is high, and distributed in farmed deer herds throughout New Zealand. CLINICAL SIGNIFICANCE: Results confirm the risk of disease and potential loss of production in deer, and exposure of infection to humans and other livestock from deer is widespread, demonstrating that control of the disease needs to be considered at a national rather than regional level.

Leptospirosis in farmed deer in New Zealand : a review.

Current knowledge of leptospirosis in farmed deer in New Zealand is reviewed. Over the past 25 years, leptospirosis has been reported to occur in individual cases as well as in herd outbreaks in farmed deer and in human cases linked to farmed deer. Serological studies and evidence from bacterial culture suggest infection is widespread. Mixing of young stock from several sources appears to be a significant risk factor for outbreaks. The culture of Leptospira interrogans serovars Hardjobovis, Pomona and Copenhageni has been reported. Infection with serovar Hardjobovis had the highest prevalence, either individually or mixed with serovar Pomona. Infection with serovar Copenhageni appears uncommon and its pathogenicity in deer is unproven. Titres to serovars Australis, Ballum, Balcanica and Tarassovi have been reported. Deer appear to be maintenance hosts for serovar Hardjobovis, incidental or accidental hosts and probably a maintenance population for serovar Pomona, since some infections persist for several months, and accidental hosts for serovar Copenhageni. Serovar Pomona appears to produce clinical and probably subclinical disease, whereas serovar Hardjobovis appears to cause only subclinical disease, although the relative risk of disease causation has not been determined. Clinical disease is usually manifested by haemolysis, jaundice, renal lesions, haemoglobinuria and often by sudden death. Renal lesions are commonly observed at slaughter and many are associated with leptospiral infections. Occupationally, slaughterhouse workers appear to be at greatest risk of contracting the disease from deer. Vaccination produces serological responses, but its effectiveness in protecting against disease, and prevention or reduction of shedding in urine, has not yet been confirmed in deer. More robust knowledge of the epidemiology of leptospiral infections in deer, and the effectiveness of vaccines and vaccination regimes, is needed to assist the deer industry to develop a strategy to manage this disease.

Efficacy, distribution and faecal excretion of copper oxide wire particles in a novel bolus in red deer (Cervus elaphus).

AIM: To determine the efficacy of a novel copper oxide wire particle (COWP) formulation in elevating concentrations of copper (Cu) in the liver and serum of red deer (Cervus elaphus), and to investigate the distribution of particles in the gastrointestinal tract and the rate of their excretion in faeces. METHODS: Mixed-age red deer hinds were allocated to three groups (n=10 per group) on the basis of pre-treatment liver Cu concentrations. Groups 1 and 2 were treated orally with a 10-g COWP bolus on Days 0 and 30, respectively, while the remaining group served as an untreated control. Animals were slaughtered on Day 60, when blood and liver samples were collected for determination of Cu concentrations. An additional group of 18-month-old red deer hinds (n=20) were treated orally with a 10-g COWP bolus, and four were slaughtered on each of Days 1, 5, 15, 30 and 60 after treatment. The gastrointestinal tract was secured between compartments below the oesophagus and contents rinsed until sedimentation of particles was complete. The sediment was oven-dried and COWP were separated and weighed. Faeces were collected continuously from four additional animals held in metabolism cages for 4 days after treatment, sub-sampled daily, and COWP recovered. RESULTS: Mean liver Cu concentrations at slaughter were 80, 597 and 447 micromol/kg for controls and hinds treated 30, and 60 days previously, respectively. Corresponding mean serum Cu concentrations were 7.7, 12.9 and 11.9 micromol/L, respectively. Liver and serum Cu concentrations were higher in both treatment groups than in untreated control animals (p<0.001). COWP were found in all compartments of the gastrointestinal tract measured, for at least 15 days, and in the rumen/reticulum and abomasum for at least 60 days post-administration. The highest rate of recovery overall was from the rumen/reticulum. Mean weight of COWP recovered from faeces was 0.09 g during the first 24 h and 0.94 g over the first 4 days following administration. CONCLUSION: The COWP bolus tested resulted in elevated mean liver Cu concentrations for at least 60 days compared with control animals. The majority of COWP were found in the rumen/ reticulum, where recovery was possible for at least 60 days. About 10% of particle weight was excreted in the faeces within 4 days of administration. CLINICAL SIGNIFICANCE: The test bolus was efficacious in deer, elevating mean liver and serum Cu concentrations 30 and 60 days after treatment. Variation in faecal excretion may explain between-animal differences in efficacy.

A survey of anthelmintic use and internal parasite control in farmed deer in New Zealand.

AIM: To survey parasite control programmes and anthelmintic usage over a 12-month period on deer farms in New Zealand. METHODS: A questionnaire of general farm data, policy and procedures for anthelmintic use, anthelmintic programmes for weaner and older deer, general information and understanding of parasite management practices was posted to 500 deer farmers in November 2004. RESULTS: Two hundred and twenty-seven (45.4%) replies were received, and 198 (39.6%) were suitable for analysis. Ninety four percent of respondents used anthelmintics at least once in the 12-month period; 53% treated all classes of deer and 22% treated only weaners. Seventy-four percent based anthelmintic dose on weight of the heaviest animal, and 36% used a weigh scale. Weaner deer (n=175 farms) were treated 1-13 (mean 3.2) times in their first 12 months, at the earliest commencing in January and at the latest in November. The mean interval between treatments ranged from 41 to 46 days. Yearling and adult hinds and stags were treated at least once (range 1-7 times) on 55-64% of farms, depending on class of animal. Moxidectin was the anthelmintic most commonly used (46-58%, depending on class of animal), followed by abamectin, eprinomectin, oxfendazole, ivermectin, albendazole, levamisole and doramectin. Perceived efficacy was the most common reason for choosing a type of anthelmintic. Weight gain and body condition were the most common measures used for monitoring parasitism in weaners and older deer, respectively, and few respondents used faecal egg and/or larval counts. Coughing and/or scouring were associated with parasitism in weaners on 13-14% of farms, and deaths associated with lungworm and gastrointestinal parasites were recorded on 5% and 3% of farms, respectively. Veterinary input to diagnosis was involved in 23% of events. Production losses and/or death of yearling and/or adult deer due to parasitism were reported by 27% of respondents. When planning anthelmintic treatment programmes, 63% of respondents followed advice from veterinarians. Thirty four percent always placed deer on clean or spelled pastures after treatment, while 32% did that often. Fifteen percent had incorporated forages and/or herbs with assumed anthelmintic properties into their parasite control programme. Forty-four percent were very confident of a return on investment when using anthelmintics for their deer. Respondents stated that their knowledge of the life cycle of the major parasites of deer was very good (8%), reasonably good (61%), poor (28%), or nil (3%). CONCLUSION: Anthelmintics are used on almost all deer farms, and practices and programmes vary considerably. Opportunities exist for veterinarians to assist deer farmer clients to improve their parasite control programmes.